IRVING, Texas, May 8, 2026 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation…
Category: News
HONEYWELL ANNOUNCES QUANTINUUM’S FILING OF REGISTRATION STATEMENT FOR PROPOSED INITIAL PUBLIC OFFERING
CHARLOTTE, N.C., May 8, 2026 /PRNewswire/ –Honeywell (NASDAQ: HON) today announced that Quantinuum, a leading, full-stack…
Hammes celebrates the completion of Boca Grande Health Clinic in Boca Grande, Florida
MILWAUKEE, May 8, 2026 /PRNewswire/ — Hammes, a national real estate consulting, development, investment and management…
TOAST! to the Children 2026 Returns to NYC, Honoring Hospitality Leader Chef Ed Brown and Supporting Critical Programs for Children and Families at Bellevue Hospital
NEW YORK, May 8, 2026 /PRNewswire/ — Children of Bellevue is proud to announce its annual…
2027 CMS Final Rule: What’s changing in Star Ratings and next steps for success
The recently released 2027 Medicare Advantage (MA) and Part D Final Rule confirms changes that many…
China Innovative Drug NHWD-870 Receives Breakthrough Therapy Designation, Bringing New Hope of Survival to NUT Carcinoma Patients
SHAOXING, China, May 9, 2026 /PRNewswire/ — Recently, the novel oral BET inhibitor NHWD-870HCI, independently developed…
Lumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery Conference
New data demonstrates ULTRApulse Alpha® CO2 effectiveness on patients with rhinophyma E‑poster highlights improved skin appearance…
PureHealth Research Announces Berberine-Infused Natural GLP-1 Supplements to Support the Body’s Native Metabolic Function
MANASSAS, Va., May 9, 2026 /PRNewswire/ — PureHealth Research is proud to introduce its advanced line…
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
NEWARK, Del., May 9, 2026 /PRNewswire/ — ACROBiosystems has implemented a major upgrade to its global…
AAVnerGene kündigt AAVone®2.1 an, eine Einzelplasmid-AAV-Produktionsplattform der nächsten Generation, die ~1e16 GC/L und >70 % volle Kapside bei der Ernte erreicht
ROCKVILLE, Maryland., 9. Mai 2026 /PRNewswire/ — USA — AAVnerGene Inc. gab heute die Markteinführung von…